loading

Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten

pulisher
Dec 07, 2025

Investment Report: How Maze Therapeutics Inc stock benefits from tech adoptionJuly 2025 Market Mood & Accurate Buy Signal Alerts - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 06, 2025

Maze Therapeutics (MAZE) Price Target Increased by 11.37% to 44.12 - Nasdaq

Dec 06, 2025
pulisher
Dec 05, 2025

Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Average Recommendation of “Buy” by Brokerages - Defense World

Dec 05, 2025
pulisher
Dec 04, 2025

Wells Fargo Initiates Coverage of Maze Therapeutics (MAZE) with Overweight Recommendation - Nasdaq

Dec 04, 2025
pulisher
Dec 04, 2025

Maze Therapeutics (NASDAQ:MAZE) Sets New 52-Week HighTime to Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Maze Therapeutics stock price target raised to $60 from $50 at H.C. Wainwright - Investing.com Canada

Dec 04, 2025
pulisher
Dec 04, 2025

A significant driver of top-line growth: Maze Therapeutics Inc (MAZE) - Setenews

Dec 04, 2025
pulisher
Dec 04, 2025

MAZE Crosses Above Average Analyst Target - Nasdaq

Dec 04, 2025
pulisher
Dec 04, 2025

Maze Therapeutics stock rating initiated at Overweight by Wells Fargo - Investing.com Canada

Dec 04, 2025
pulisher
Dec 03, 2025

HC Wainwright & Co. Maintains Maze Therapeutics (MAZE) Buy Recommendation - Nasdaq

Dec 03, 2025
pulisher
Dec 03, 2025

MAZE: Pivotal APOL1 kidney disease data and new phase 2 studies are set for 2026, driving major growth - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

MAZE: Pivotal APOL1 kidney disease data and new phase 2 studies are set for 2026 - TradingView

Dec 03, 2025
pulisher
Dec 02, 2025

Maze Therapeutics (MAZE) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Virtus Investment Advisers LLC Invests $85,000 in Maze Therapeutics, Inc. $MAZE - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Ensign Peak Advisors Inc Buys Shares of 18,539 Maze Therapeutics, Inc. $MAZE - Defense World

Dec 02, 2025
pulisher
Nov 29, 2025

Maze Therapeutics stock hugs flat line following $140M IPO - MSN

Nov 29, 2025
pulisher
Nov 28, 2025

Technical Analysis of Maze Therapeutics, Inc. (NASDAQ:MAZE) - TradingView

Nov 28, 2025
pulisher
Nov 27, 2025

What dividend safety score for Maze Therapeutics Inc. stockMarket Sentiment Report & Technical Confirmation Trade Alerts - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

How Maze Therapeutics Inc. stock benefits from tech adoption2025 Geopolitical Influence & Weekly Setup with High ROI Potential - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 21, 2025

Will Maze Therapeutics Inc. stock sustain high P E ratiosTrade Entry Report & Weekly Setup with ROI Potential - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Maze Therapeutics Inc. stock benefit from commodity pricesAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 8.4%Should You Buy? - MarketBeat

Nov 20, 2025
pulisher
Nov 19, 2025

Price action breakdown for Maze Therapeutics Inc.2025 Stock Rankings & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Maze Therapeutics Inc. stock recession proofJuly 2025 PostEarnings & Safe Capital Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Maze Therapeutics Inc. stock momentum explainedJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Heatmap analysis for Maze Therapeutics Inc. and competitorsLong Setup & Consistent Income Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Maze Therapeutics Inc. stock deliver consistent dividendsStock Surge & AI Based Buy and Sell Signals - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Applying chart zones and confluence areas to Maze Therapeutics Inc.Entry Point & Long-Term Safe Return Strategies - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Can you recover from losses in Maze Therapeutics Inc.Quarterly Profit Report & Free Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Pattern recognition hints at Maze Therapeutics Inc. upsideJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Maze Therapeutics Inc. stock attractive for long term wealth buildingJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Maze Therapeutics (NASDAQ:MAZE) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Nov 16, 2025
pulisher
Nov 15, 2025

Will Maze Therapeutics Inc. outperform the marketOptions Play & High Win Rate Trade Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How institutional buying supports Maze Therapeutics Inc. stock2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com

Nov 15, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):